139 related articles for article (PubMed ID: 16730491)
1. Preferences between injectable contraceptive methods among South African women.
Morroni C; Myer L; Moss M; Hoffman M
Contraception; 2006 Jun; 73(6):598-601. PubMed ID: 16730491
[TBL] [Abstract][Full Text] [Related]
2. Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
Beksinska ME; Rees HV
Afr J Reprod Health; 2001 Dec; 5(3):84-8. PubMed ID: 12471932
[TBL] [Abstract][Full Text] [Related]
3. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
[TBL] [Abstract][Full Text] [Related]
4. Statement on injectable contraception.
International Planned Parenthood Federation IPPF
IPPF Med Bull; 1982 Dec; 16(6):3-4. PubMed ID: 12338511
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
Myer L; Denny L; Wright TC; Kuhn L
Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of injectable contraceptive users in a low-income population in Texas.
Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED
Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
8. Facts about injectable contraceptives: memorandum from a WHO meeting.
Bull World Health Organ; 1982; 60(2):199-210. PubMed ID: 6213318
[TBL] [Abstract][Full Text] [Related]
9. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
[TBL] [Abstract][Full Text] [Related]
10. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
11. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
Smit J; Gray A; McFadyen L; Zuma K
BMC Health Serv Res; 2001; 1():4. PubMed ID: 11401729
[TBL] [Abstract][Full Text] [Related]
12. Long acting injectable hormonal contraceptives.
Fraser IS
Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
[TBL] [Abstract][Full Text] [Related]
13. Once-a-month injectable contraceptives.
d'Arcangues C
World Health Forum; 1993; 14(4):439-40. PubMed ID: 8185807
[TBL] [Abstract][Full Text] [Related]
14. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
[TBL] [Abstract][Full Text] [Related]
15. Injectable contraception: the USA perspective.
Kaunitz AM
IPPF Med Bull; 1992 Dec; 26(6):1-3. PubMed ID: 12346920
[TBL] [Abstract][Full Text] [Related]
16. Depot-medroxyprogesterone acetate contraception use among Salvadoran women: an in-depth analysis of attitudes and experiences.
Cremer M; Ditzian L; April A; Peralta E; Klausner D; Podolsky R; Dierking E
J Womens Health (Larchmt); 2011 Nov; 20(11):1751-6. PubMed ID: 21823919
[TBL] [Abstract][Full Text] [Related]
17. Statement on injectable contraception. Revised.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921
[TBL] [Abstract][Full Text] [Related]
18. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
Canto de Cetina TE; Luna MO; Cetina Canto JA; Bassol S
Contraception; 2004 Feb; 69(2):115-9. PubMed ID: 14759615
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
20. Choice of injectables in family planning programmes.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1992 Apr; 26(2):4. PubMed ID: 12320072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
